Epidemic investigation of benign prostatic obstruction with coexisting overactive bladder in Shanghai Pudong New Area and its impact on the health-related quality of life
- PMID: 31481034
- PMCID: PMC6724326
- DOI: 10.1186/s12894-019-0513-1
Epidemic investigation of benign prostatic obstruction with coexisting overactive bladder in Shanghai Pudong New Area and its impact on the health-related quality of life
Abstract
Background: We aimed to investigate the prevalence, relative risk factors, and the impact on the health-related quality of life (HRQoL) of benign prostatic obstruction (BPO) with coexisting overactive bladder (OAB) in men aged over 50 and living in Shanghai Pudong New Area.
Methods: Using a multi-stage sampling and descriptive epidemiological method, 1632 men were selected from among the general population. Participants completed an evaluation of lower urinary tracts symptoms (LUTS), including international prostate symptom score (IPSS) and quality of life (QoL) questionnaires. Erectile function was assessed using the International Index of Erectile Function-5 (IIEF-5) questionnaire. In addition, the Overactive Bladder Symptom Score (OABSS) and King's health questionnaire (KHQ) were used to assess the impact of BPO with coexisting OAB on the HRQoL. Maximum flow rate (Qmax), postvoid residual urine volume (PVR) and prostate-specific antigen (PSA) were also recorded.
Results: A total of 1476 men with complete data were analyzed. The overall prevalence of BPO with coexisting OAB was 39.6%. Age and prostate volume were associated risk factors for BPO with coexisting OAB. In addition, BPO with coexisting OAB negatively impacted the HRQoL, with increased IPSS, QoL, OABSS, and KHQ scores and decreased IIEF-5 scores compared to that in patients with BPO without OAB.
Conclusions: Qmax, PVR and serum PSA did not predict whether the patients had a combined BPO + OAB or not. The prostate volume and age were associated risk factors for BPO with coexisting OAB. BPO is a progressive disease and may be one of the risk factors for OAB.
Keywords: Benign prostatic obstruction; Epidemic investigation; Health-related quality of life; Overactive bladder.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia.Urology. 2013 Jul;82(1):189-93. doi: 10.1016/j.urology.2013.02.024. Epub 2013 May 2. Urology. 2013. PMID: 23642937
-
The add-on effect of solifenacin for patients with remaining overactive bladder after treatment with tamsulosin for lower urinary tract symptoms suggestive of benign prostatic obstruction.Adv Urol. 2010;2010:205251. doi: 10.1155/2010/205251. Epub 2010 Oct 26. Adv Urol. 2010. PMID: 20981257 Free PMC article.
-
Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment.Int J Urol. 2008 Aug;15(8):709-15. doi: 10.1111/j.1442-2042.2008.02097.x. Epub 2008 Jul 24. Int J Urol. 2008. PMID: 18662175 Clinical Trial.
-
Treatment of overactive bladder in men: Is it really different?Neurourol Urodyn. 2022 Nov;41(8):1975-1982. doi: 10.1002/nau.25000. Epub 2022 Jul 3. Neurourol Urodyn. 2022. PMID: 35781322 Review.
-
Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?Curr Opin Urol. 2016 Jan;26(1):17-21. doi: 10.1097/MOU.0000000000000249. Curr Opin Urol. 2016. PMID: 26574877 Review.
Cited by
-
Inhibition of DNA methylation during chronic obstructive bladder disease (COBD) improves function, pathology and expression.Sci Rep. 2021 Aug 27;11(1):17307. doi: 10.1038/s41598-021-96155-4. Sci Rep. 2021. PMID: 34453065 Free PMC article.
-
A Comparative Study on the Clinical Outcomes of Bipolar Radiofrequency Thermotherapy Versus Transurethral Resection of the Prostate in Storage Symptoms Associated With Benign Prostatic Obstruction.Int Neurourol J. 2024 Dec;28(4):285-293. doi: 10.5213/inj.2346184.092. Epub 2024 Dec 31. Int Neurourol J. 2024. PMID: 39765341 Free PMC article.
-
Barriers to early and effective overactive bladder management in male patients with lower urinary tract symptoms.PLoS One. 2025 Jul 23;20(7):e0328723. doi: 10.1371/journal.pone.0328723. eCollection 2025. PLoS One. 2025. PMID: 40700381 Free PMC article.
References
-
- Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology. 2002;60(1):7. - PubMed
-
- Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Kerrebroeck PV, Victor A, Wein A. The standardization of terminology of lower urinary tract function: report from the standardisation subcommittee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–178. - PubMed
-
- Mattiasson A, Djurhuus JC, Fonda D, Lose G, Nordling J, Stöhrer M. Standardization of outcome studies in patients with lower urinary tract dysfunction: a report on general principles from the standardisation committee of the international continence society. Neurourol Urodyn. 1998;17(3):249–253. - PubMed
-
- Doward LC, Mckenna SP. Defining patient-reported outcomes. Value Health. 2004;7(S1):S4. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous